The only CRO specialized in full human immune system and liver mouse disease models for Cancer, Infectious, Metabolic diseases, Human Drug Metabolism, Inflammation and Vaccines. Our goal is to offer predictive in vivo pharmacology tools for studying diseases of the human immune system, tumor, liver, pancreas, and skin. We offer access to humanized mouse models for preclinical drug development targeting diseases such as Cancer (CDX and PDX), HIV, HBV, inflammatory (e.g. colitis, NASH, fibrosis).
Your Advantages: – Save Time and Budget – Focus on the most promising clinical candidate – HuData for IND filling – One-stop-shop for in vivo pharmacology – De-risking Translational Projects – Flexibility and Adaptability – Competitive FTE Rate – Access to BSL-2 and 3 lab, and animal facilities – Tailored-made protocols and study designs Our Assets: – >50 fully detailed CDX’s for I-O, cancer studies – Biosafety level-2 and -3 accredited animal & lab facilities – State of the Art Flow Cytometry Platform – Cell culture and Molecular Biology facilities – Optimized tailor-made protocol designs – High quality and Pharma experienced team – Recognized expertise in flow cytometry analysis – Innovation programs: EU grants: Eurostars, Interreg & Horizon 2020 – AAALAC accreditation